Trending

amyloid

Surprise! Biogen says Alzheimer’s drug works after all and will be filed

Surprise! Biogen says Alzheimer’s drug works after all and will be filed

Mere months ago Biogen’s Alzheimer’s drug aducanumab was being written off as the latest amyloid-targeting dud. Now, its

X

Surprise! Biogen says Alzheimer’s drug works after all and will be filed

https://pharmaphorum.com/news/surprise-biogen-says-alzheimers-drug-works-after-all-and-will-be-filed/

A bright future for CNS and Alzheimer’s?

A bright future for CNS and Alzheimer’s?

Swiss biotech Asceneuron is developing what could be the first treatment for progressive supranuclear palsy (PSP), a rare

X

A bright future for CNS and Alzheimer’s?

https://pharmaphorum.com/r-d/views-analysis-r-d/a-bright-future-for-cns-and-alzheimers/

Biogen drug shows potential in Alzheimer’s

Biogen drug shows potential in Alzheimer’s

Phase 1b trial shows aducanumab clears brain plaques.

X

Biogen drug shows potential in Alzheimer’s

https://pharmaphorum.com/news/biogen-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com